Sign In
Buy VRPX
Virpax Pharmaceuticals Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 4.66M and sold 0 VRPX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
0 |
| ● Buy | 4.66M shares |
| ● Sell | 0 shares |
|
100% Buy Activity
Negligible or No Correlation
|
|
No Significant SignalsNo statistically significant buy or sell signals detected in recent insider data. |
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
May 18, 2022 Buy |
Floyd Eric |
4 479 Value: $6K |
||
|
May 18, 2022 Buy |
Mack Anthony P. Chief Executive Officer |
75 750 Value: $101.5K |
||
|
May 18, 2022 Buy |
Floyd Eric |
4 479 Value: $6K |
||
|
Apr 25, 2022 Buy |
Bruce Gerald W |
60 000 Value: $0 |
||
|
Apr 25, 2022 Buy |
Bruce Gerald W |
60 000 Value: $0 |
||
|
Apr 07, 2022 Buy |
Mathias Sheila Chief Scientific Officer |
25 000 Value: $115.5K |
||
|
Apr 07, 2022 Buy |
Mathias Sheila Chief Scientific Officer |
25 000 Value: $115.5K |
||
|
Jan 31, 2022 Buy |
Gudin Jeffrey Chief Medical Officer |
60 676 Value: $129.2K |
||
|
Jan 31, 2022 Buy |
Mack Anthony P. Chief Executive Officer |
60 676 Value: $129.2K |
||
|
Jan 31, 2022 Buy |
Chipman Christopher Michael Chief Financial Officer |
60 676 Value: $129.2K |
||
|
Jan 31, 2022 Buy |
Gudin Jeffrey Chief Medical Officer |
60 676 Value: $129.2K |
||
|
Jan 31, 2022 Buy |
Mack Anthony P. Chief Executive Officer |
60 676 Value: $129.2K |
||
|
Jan 31, 2022 Buy |
Chipman Christopher Michael Chief Financial Officer |
60 676 Value: $129.2K |
||
|
Jan 31, 2022 Buy |
Mack Anthony P. Chief Executive Officer |
150 000 Value: $351.0K |
||
|
Jan 31, 2022 Buy |
Gudin Jeffrey Chief Medical Officer |
100 000 Value: $213.0K |
||
|
Jan 31, 2022 Buy |
Chipman Christopher Michael Chief Financial Officer |
100 000 Value: $213.0K |
||
|
Jan 31, 2022 Buy |
Mack Anthony P. Chief Executive Officer |
150 000 Value: $351.0K |
||
|
Jan 31, 2022 Buy |
Gudin Jeffrey Chief Medical Officer |
100 000 Value: $213.0K |
||
|
Jan 31, 2022 Buy |
Chipman Christopher Michael Chief Financial Officer |
100 000 Value: $213.0K |
||
|
Jan 01, 2022 Buy |
Sendrow Jerrold Director |
12 091 Value: $41.5K |
||
|
Jan 01, 2022 Buy |
Jambulingam Thani Director |
14 113 Value: $48.4K |
||
|
Jan 01, 2022 Buy |
Singh Vanila Director |
12 091 Value: $41.5K |
||
|
Jan 01, 2022 Buy |
Dubin Michael F Director |
12 091 Value: $41.5K |
||
|
Jan 01, 2022 Buy |
Floyd Eric Director |
15 124 Value: $51.9K |
||
|
Jan 01, 2022 Buy |
Jacob Gary S Director |
12 091 Value: $41.5K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
